The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Seely Lynn since 2020.
This trader's CIK number is 1327111.
At the time of last reporting, Seely Lynn was the President and CEO of Lyell Immunopharma, Inc.. (stock ticker symbol LYEL).
Also see all insider trading activities at Lyell Immunopharma, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | LYEL | 175,000 | $106,225 | 8,054 | $84,829 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | BPMC | 0 | $0 | 0 | $0 | 1,312 | $0 |
1. Lyell Immunopharma, Inc. (LYEL)
2. Blueprint Medicines Corp (BPMC)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-21 | LYEL | Sale | 7,257 | 10.54 | 76,517 |
2025-08-12 | LYEL | Sale | 406 | 10.34 | 4,197 |
2025-08-11 | LYEL | Sale | 391 | 10.53 | 4,115 |
2025-03-14 | LYEL | Buy | 175,000 | .61 | 106,225 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-06-19 | BPMC | Option Ex | 1,312 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Seely Lynn (President and CEO of Lyell Immunopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.